购物车
您的购物车当前为空
GSK163929 (compound 122) 是一种口服活性强的抗HIV CCR5拮抗剂,对hEGR的抑制效力较低。在 2000 mg/kg/day (i.v., 7 d) 的剂量下对大鼠无明显毒性,在 250 mg/kg/day (i.v., 7 d) 的剂量下对狗也未见不良反应。

GSK163929 (compound 122) 是一种口服活性强的抗HIV CCR5拮抗剂,对hEGR的抑制效力较低。在 2000 mg/kg/day (i.v., 7 d) 的剂量下对大鼠无明显毒性,在 250 mg/kg/day (i.v., 7 d) 的剂量下对狗也未见不良反应。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
| 产品描述 | GSK163929 (compound 122) is an orally active CCR5 antagonist with anti-HIV properties and demonstrates low inhibitory potency against hEGR. Administered at a dosage of 2000 mg/kg/day (i.v., 7 d), it shows no adverse effects in rats, and at 250 mg/kg/day (i.v., 7 d), it is similarly non-toxic in dogs. |
| 分子量 | 696.25 |
| 分子式 | C36H40ClF2N5O3S |
| CAS No. | 716354-04-0 |
| Smiles | C(CN1[C@@]2(C[C@H](C[C@]1(CC2)[H])N3C=4C(N=C3C)=CC=CC4)[H])C5(CCN(C(=O)C6=CC(S(NC)(=O)=O)=C(F)C=C6Cl)CC5)C7=CC(F)=CC=C7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多